122 related articles for article (PubMed ID: 16708300)
21. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.
Rehfeld N; Geddert H; Atamna A; Gabbert HE; Steidl U; Fenk R; Kronenwett R; Haas R; Rohr UP
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of unique human gallbladder cancer cell lines.
Ghosh M; Koike N; Yanagimoto G; Tsunoda S; Kaul S; Hirano T; Emura F; Kashiwagi H; Kawamoto T; Ohkohchi N; Saijo K; Ohno T; Miwa M; Todoroki T
Int J Oncol; 2004 May; 24(5):1189-96. PubMed ID: 15067341
[TBL] [Abstract][Full Text] [Related]
23. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial.
Fiorentini G; Rossi S; Lanzanova G; Biancalani M; Palomba A; Bernardeschi P; Dentico P; De Giorgi U
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):17-20. PubMed ID: 16767900
[TBL] [Abstract][Full Text] [Related]
25. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
Zigeuner R; Ratschek M; Langner C
BJU Int; 2005 Feb; 95(3):315-8. PubMed ID: 15679785
[TBL] [Abstract][Full Text] [Related]
26. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of outcome in 63 gallbladder carcinoma patients after radical resection.
Yagi H; Shimazu M; Kawachi S; Tanabe M; Aiura K; Wakabayashi G; Ueda M; Nakamura Y; Kitajima M
J Hepatobiliary Pancreat Surg; 2006; 13(6):530-6. PubMed ID: 17139427
[TBL] [Abstract][Full Text] [Related]
28. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
29. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
30. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma.
Krasagakis K; Kruger-Krasagakis S; Eberle J; Tsatsakis A; Tosca AD; Stathopoulos EN
Dermatology; 2009; 218(1):37-43. PubMed ID: 19001805
[TBL] [Abstract][Full Text] [Related]
31. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
32. C-kit expression in high-risk breast cancer subgroup treated with high-dose or conventional dose-dense chemotherapy.
Diallo R; Ting E; Gluz O; Herr A; Schütt G; Geddert H; Mohrmann S; Gabbert HE; Nitz U; Poremba C
Verh Dtsch Ges Pathol; 2006; 90():177-85. PubMed ID: 17867595
[TBL] [Abstract][Full Text] [Related]
33. CD117 (c-kit) expression in human hepatocellular carcinoma.
Becker G; Schmitt-Graeff A; Ertelt V; Blum HE; Allgaier HP
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):204-8. PubMed ID: 17359908
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
Liegl B; Leithner A; Bauernhofer T; Windhager R; Guelly C; Regauer S; Beham A
Histopathology; 2006 Dec; 49(6):576-81. PubMed ID: 17163842
[TBL] [Abstract][Full Text] [Related]
35. Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification.
Shimizu H; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
J Hepatobiliary Pancreat Surg; 2007; 14(4):358-65. PubMed ID: 17653633
[TBL] [Abstract][Full Text] [Related]
36. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
37. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptors in gallbladder cancer: detection by an improved immunohistochemical assay.
Ko CY; Schmit P; Cheng L; Thompson JE
Am Surg; 1995 Oct; 61(10):930-3. PubMed ID: 7668471
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
Giatromanolaki A; Sivridis E; Simopoulos C; Polychronidis A; Gatter KC; Harris AL; Koukourakis MI
J Surg Oncol; 2006 Sep; 94(3):242-7. PubMed ID: 16900513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
